Pharmacological treatment options for autism spectrum disorders in children and adolescents

Harv Rev Psychiatry. 2008;16(2):97-112. doi: 10.1080/10673220802075852.

Abstract

Autism and other pervasive developmental disorders (PDDs) are frequently associated with dysfunctional behaviors and are characterized by deficits in socialization, communication, and behavioral rigidity. Despite the absence of a pharmacological cure for PDDs, many of the dysfunctional, coinciding behaviors may be treated pharmacologically. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from autistic spectrum disorders.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Asperger Syndrome / diagnosis
  • Asperger Syndrome / drug therapy*
  • Asperger Syndrome / psychology
  • Autistic Disorder / diagnosis
  • Autistic Disorder / drug therapy*
  • Autistic Disorder / psychology
  • Behavior Therapy
  • Child
  • Child Behavior Disorders / diagnosis
  • Child Behavior Disorders / drug therapy
  • Child Behavior Disorders / psychology
  • Child Development Disorders, Pervasive / diagnosis
  • Child Development Disorders, Pervasive / drug therapy*
  • Child Development Disorders, Pervasive / psychology
  • Child, Preschool
  • Combined Modality Therapy
  • Communication
  • Controlled Clinical Trials as Topic
  • Humans
  • Language Therapy
  • Occupational Therapy
  • Psychotropic Drugs / therapeutic use*
  • Socialization
  • Speech Therapy
  • Treatment Outcome

Substances

  • Psychotropic Drugs